Pemazyre OverviewPemigatinib (INN), sold under the brand name Pemazyre, is a medication for the treatment of adults with previously treated, unresectable locally advanced or metastatic bile duct cancer (cholangiocarcinoma) with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test. Pemigatinib works by blocking FGFR2 in tumor cells to prevent them from growing and spreading. P...
Read more Pemazyre Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pemigatinib
Recent Pemazyre Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 13.5mg, 4.5mg, 9mg
NDC Database Records for Pemazyre: (3 results)Sorted by National Drug Code
- 50881-026 Pemazyre 4.5 mg Oral Tablet by Incyte Corporation
- 50881-027 Pemazyre 9 mg Oral Tablet by Incyte Corporation
- 50881-028 Pemazyre 13.5 mg Oral Tablet by Incyte Corporation